• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:吴静成,陈枢青,周展.肿瘤新抗原预测方法研究进展[J].中国现代应用药学,2022,39(21):2879-2886.
WU Jingcheng,CHEN Shuqing,ZHOU Zhan.Advances in Tumor Neoantigen Prediction Methods[J].Chin J Mod Appl Pharm(中国现代应用药学),2022,39(21):2879-2886.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1333次   下载 1958 本文二维码信息
码上扫一扫!
分享到: 微信 更多
肿瘤新抗原预测方法研究进展
吴静成, 陈枢青, 周展
浙江大学药学院, 浙江省抗肿瘤药物临床前研究重点实验室, 杭州 310058
摘要:
肿瘤新抗原是一类肿瘤特异性抗原,是潜在的肿瘤免疫治疗理想靶标。由于肿瘤新抗原产生及刺激T细胞应答的生理过程复杂,如何高效地发现与鉴定肿瘤新抗原仍是一个巨大的挑战。随着肿瘤免疫基因组学数据的积累和人工智能预测方法的深入研究,研究者能够借助人工智能新算法进行肿瘤新抗原预测方法的研究,为基于肿瘤新抗原的肿瘤免疫治疗奠定坚实的基础。本文围绕肿瘤新抗原胞内处理、抗原提呈和T细胞识别等生理过程系统综述了肿瘤新抗原预测方法的进展。
关键词:  肿瘤新抗原  肿瘤免疫治疗  抗原提呈  预测方法  人工智能
DOI:10.13748/j.cnki.issn1007-7693.2022.21.026
分类号:
基金项目:国家自然科学基金项目(U20A20409,31971371)
Advances in Tumor Neoantigen Prediction Methods
WU Jingcheng, CHEN Shuqing, ZHOU Zhan
Zhejiang University, College of Pharmaceutical Sciences, Zhejiang Key Laboratory of Preclinical Research on Antitumor Drugs, Hangzhou 310058, China
Abstract:
Neoantigen is tumor specific antigen and a promising target for tumor immunotherapy. However, due to the complex physiological process of neoantigen generating and stimulating T cell response, it’s still a huge challenge to discover and identify neoantigen efficiently. With the accumulation of tumor immunogenomics data and the in-depth study of artificial intelligence prediction methods, researchers could take advantage of artificial intelligence algorithms for neoantigen prediction methods, laying a solid foundation for tumor immunotherapy based on neoantigens. The research reviewed the advances in tumor neoantigen prediction methods for antigen processing and presenting, as well as antigen recognition by T cells.
Key words:  tumor neoantigen  tumor immunotherapy  antigen presenting  prediction method  artificial intelligence
扫一扫关注本刊微信